United Kingdom · Telehealth platform · Brand-name
PrivateDoc review
Publishes the full five-week titration schedule alongside the price — clinical detail almost no commercial page bothers with.
Overview
PrivateDoc sells Nevolat, which it describes plainly as “generic Saxenda,” containing liraglutide. Pricing is by pen count rather than by month: £64.99 for one pen covering 17 days, £99.99 for two covering three and a half weeks, £143.99 for three covering four and a half weeks, and £199.99 for five covering six weeks.
The standout is the titration schedule, published in full: 0.6 mg daily in week one, 1.2 mg in week two, 1.8 mg in week three, 2.4 mg in week four, and a 3.0 mg maintenance dose from week five. Publishing the escalation plan lets a buyer work out what a steady month actually costs, and lets them recognise a service that is escalating them faster than the label suggests.
Prescribing requires “a successful clinical assessment by our healthcare team,” with treatment reviewed by GMC-registered doctors, advanced nurse practitioners and prescribing pharmacists. BMI criteria are not stated.
Medications and supply
Generic liraglutide. Note that Novo Nordisk is discontinuing branded Saxenda; the generic is a separate product.
- Nevolat (generic liraglutide, described as generic Saxenda)
How the service works
- Consultation
- A successful clinical assessment by the healthcare team is required before a prescription is issued.
- Eligibility
- Determined by clinical assessment. BMI thresholds are not stated.
- Provider involvement
- GMC-registered doctors, advanced nurse practitioners and prescribing pharmacists reviewing treatment.
- Lab requirements
- Not stated in the sources we checked.
- Pharmacy fulfilment
- Not stated in the sources we checked.
- Shipping
- Not stated in the sources we checked.
- Support services
- Not stated in the sources we checked.
What it costs
| Item | Published price | Notes |
|---|---|---|
| 1 pen | £64.99 | covers 17 days |
| 2 pens | £99.99 | covers 3.5 weeks |
| 3 pens | £143.99 | covers 4.5 weeks |
| 5 pens | £199.99 | covers 6 weeks |
- Membership fee
- None.
- Medication fee
- Priced by pen count with the duration each covers stated.
- Insurance
- Not stated in the sources we checked.
- HSA / FSA
- Not stated in the sources we checked.
- Cancellation
- Not stated in the sources we checked.
- Refunds
- Not stated in the sources we checked.
Pros
- Publishes the full week-by-week titration schedule, which almost no commercial page does
- Prices by pen count with the days covered stated, so cost per day is calculable
- Names the clinician types — GMC doctors, ANPs and prescribing pharmacists
- Describes Nevolat honestly as generic Saxenda
Cons
- Single medication — liraglutide only, the least effective of the injectable options
- No BMI criteria published
- Nothing on shipping, cancellation or refunds
Who it may suit
A UK buyer considering liraglutide who wants to see the escalation plan before starting.
Limitations
- UK market only
- Liraglutide’s trial average of 8.0% is well below semaglutide and tirzepatide
Questions
How does the dose escalate?
PrivateDoc publishes it: 0.6 mg daily in week one, 1.2 mg week two, 1.8 mg week three, 2.4 mg week four, then 3.0 mg maintenance from week five.
Is Nevolat the same as Saxenda?
It is the generic of it — the same molecule, liraglutide. PrivateDoc describes it as “generic Saxenda.” Novo Nordisk is discontinuing the branded product.
Sources
Everything on this page traces to one of the links below, retrieved on the date shown. Prices and programme terms in this market change without notice — confirm against the provider before you buy.
- 01PrivateDoc — Nevolat pricing by pen, titration schedule, prescriber credentialsretrieved 2026-08-15